DMRA — Damora Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing
Brief: Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett As President And Chief Executive Officer
Brief: Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Micron, McDonald's, Generac
U.S. STOCKS ON THE MOVE-Klaviyo, Frontier Group, Wabtec
U.S. STOCKS ON THE MOVE-Shopify, GlobalFoundries, Constellation Energy
Biopharma co Galecto drops after $275 mln stock sale
Brief: Galecto Announces Pricing Of $275 Million Underwritten Public Offering
Brief: Galecto Inc Hans T. Schambye To Cease Serving As CEO And President
U.S. RESEARCH ROUNDUP-KKR, Sirius XM, Workday
Brief: Galecto Announces Key Additions To Leadership Team
Brief: Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Cancer drug developer Galecto's Q3 net loss narrows to $3.1 mln
Brief: Galecto Q3 Operating Income USD -3.156 Million
Brief: Galecto Q2 Operating Income USD -3.421 Million